EVENTS

Korea - Pharmaceutical Powerhouse of the Future!

If you are looking for business opportunities in the fast growing Korean pharma market and surrounding region, CPhI Korea 2017 will present an ideal opportunity.

The three-day event will include networking opportunities and a high-content conference programme emphasising CPhI Korea's role in enabling international and domestic business.

The entire Pharma Industry in one location:

  *  CPhI: for pharmaceutical ingredients
  *  iCSE: for contract manufacturing and services
  *  P-MEC: for pharmaceutical machinery technology and equipment
  *  BioPh: for biopharmaceutical development and services
  *  Health Ingredients Korea: for the fast growing ingredients market of Korea (including health, pharma and nutraceuticals)

The 4th International Symposium of Materials on Regenerative Medicine (2017 ISOMRM) will be held from August 23-26 in Aspire Resort, Taoyuan, Taiwan. To promote international exchange in biomaterials for biomedical research and enhance the international influence of biomaterials research for regenerative medicine and associated academic societies, the National Health Research Institute Taiwan organized the 1st ISOMRM back in 2010, sharing the research of biomaterials in regenerative medicine, enhancing international exchange, and introducing Taiwan’s biomaterials and regenerative medicine to the international community. 2017 ISOMRM is in conjunction with 1. East West Asia Biomaterials Symposium; 2. Russian-Taiwanese Symposium on Nanobiology & Nanomedicine. Nearly thirty foreign and domestic experts in the fields of regenerative medicine and biomaterials are invited to deliver speeches. Around 300 to 500 colleagues will be joined us this year and approximately 250 oral abstracts and 200 posters will be accepted. They will be sharing the latest applied research and development trends, therefore exciting content is to be anticipated. The theme topics of 2017 ISOMRM includes Biomaterials for Tissue Regeneration, Clinical Tissue Engineering, Regulation and Induction of Stem Cells, Biomedical Polymers, Ceramics and Metals, Bioinspired Smart Materials, Mechanobiology, 3D Printing, Drug/Gene Delivery, Cell Therapy, etc.

The Immuno-Oncology Summit will return to Boston again this August 28-September 1 with the goal of supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers. This year's IO Summit has been designed to give attendees a complete picture of the field and its advances with 12 conference tracks, 1 in-depth training seminar, and 4 instructional short courses. Topics include immunotherapy discovery, development, biomarkers, and translational oncology as well as emerging topic areas such as cancer vaccines, oncolytic viruses, and advances in synthetic biology techniques. Overall, this event provides a focused look at how researchers are applying new science and technology in the development of effective and safe immunotherapies.

Innovative solutions to the greatest challenges in pharmaceutical development

The growth of biopharma and patient compliance issues have encouraged us to adopt a drug delivery mind set from discovery through to production.

Every year we see innovation and breakthroughs at every level of drug development. The DDF Summit brings the most innovative and exciting studies to you.

Covering both small molecules and biologics, you’ll find new technologies, concepts and case studies in areas such as.

•    Formulation design for poorly soluble compounds
•    The potential of nanotechnology for better deliverability
•    The latest controlled released technologies
•    Improving patient compliance by harnessing data and the latest smart device technology
•    Optimising formulations for continuous manufacturing
•    Overcoming the blood brain barrier and challenges in oral delivery of biologics
•    Reformulation and biosimilars

Over the past decade, biomanufacturing has become a strategic driver to scalable and flexible operations, controlled costs, and high quality drug market access.1 The advances in manufacturing technologies–in particular continuous manufacturing, process analytical technology, single-use systems, alternative down processing techniques and drug device systems–continue to influence the biopharmaceutical workforce, impacting the manufacturers’ collaboration strategies and their choices of facility locations.

In the upcoming BIOMANUFACTURING GLOBAL CONGRESS 2017 EUROPE, a more reactive and dynamic approach to key trends, methodologies and insights on manufacturing, supply chain, quality management and compliance than the current industry standard is anticipated.

Gain Latest Insights On:

•        Critical trends driving biomanufacturing production strategies
•        Capacity-enhancing approaches ranging from technology solutions to business strategiesp
•        Updates on emerging technologies and methods to cut costs and improve production efficiency
•        Overarching industry pressures that are driving capacity needs and subsequent regulatory compliance
•        Benchmarking manufacturing performance through metrics
•        Mitigating supply chain risk through improved confidence

Arena International’s flagship Outsourcing in Clinical Trials New England conference is back and better than ever with a brand new clinical trial technology and innovation track! Join us in Boston on 6/7 September this year for cutting-edge content delivered by speakers from some of the most exciting biotech, pharmaceutical and medical device companies in New England.

Focused on equipping you with the tools necessary to optimise your clinical outsourcing strategies and in-house processes, this year’s agenda is packed with a host of interactive sessions and case-study presentations. Find out how to better manage vendor contracts, overcoming the challenges of using mobile devices in trials and how your colleagues are aligning with ICH E6.

BioTech 2017 will provide an interdisciplinary discussion forum for experts in the field of (bio)process analytics and sensor technology. With a strong focus on applications, the conference aims at bringing together scientists and professionals from both industry and academia.

The conference will be held on 7 and 8 September 2017 at the Zurich University of Applied Sciences, Wädenswil, Switzerland. It will be dedicated to the latest developments in the following fields:

•    At-line process monitoring and control
•    Online biomass sensing
•    Sensors and biosensors in biotech applications
•    Visions and perspectives in bioprocess applications

Pharmac India is 8th International Pharma Machinery, Equipment, Bulk Drugs, API, Pharma Lab, Pharma Pack & Material Exhibition in India. It has successfully brought together manufacturers and buyers on a common platform and contributed substantially towards the growth of the industry.

Pharmac India 2017 is jointly organized by Orbit Exhibitions Pvt. Ltd. & Indian Drug Manufacturers’ Association (IDMA-GSB).

The 2017 FIP congress in Seoul, South Korea, invites an international audience of pharmacy professionals and pharmaceutical scientists to go beyond medicines and answer patients’ demand for high quality help and advice. At this year’s congress, the professional symposia will explore the many new ways that pharmacy professionals can add the value expected by modern health care systems and services. Sessions will show that tradition and dedication to patients’ health – the true soul of pharmacy – can be coupled with innovation in technology, education and practice to deliver care for the 21st century.

Seoul, the heart of the nation and home to 10 million national and foreign residents is a remarkable world-class city where contemporary lifestyle meets long-standing history. This vibrant city houses 266 cultural properties against a backdrop of towering skyscrapers, and serves as the proud epicentre of the Korean Wave pop culture phenomenon or Hallyu, attracting many from all over the world.

Multilingual signage, end-to-end public transportation system and eco-friendly technologies used throughout the city make Seoul a comprehensive and convenient city to travel and from European to African and Arabic to Asian, international cuisines with Korean traditional and modern gastronomy, all participants regardless of age, gender, ethnicity and religion shall be satis ed, all reasonable price range. Crime rates against nationals and foreign visitors are extremely low, in comparison to other major cities in the world (Sourced by UNODC).

Come and be amazed by this bustling city where thousands of years of ancient Korean culture mingle with globalization, urbanization and modernization on an unprecedented scale.

For more than 25 years, the U.S. FDA and PDA have collaborated on the PDA/FDA Joint Regulatory Conference, a premier pharmaceutical manufacturing industry event where participants have the unique opportunity to engage directly with FDA representatives and industry experts. Attendees return to this popular Conference year after year to hear FDA regulators provide updates on current efforts affecting the development of global regulatory strategies, and industry experts present case studies illustrating how they use global strategies to improve the quality of medical products.

Built around the exciting theme, “Ensuring Product Quality in an Era of Innovative Therapies,” this year’s Conference agenda will highlight the advanced biomedical innovations leading to safer and more effective therapies for patients. Plenary, concurrent, breakfast and interest group sessions will provide new perspectives and best practices on a variety of important industry topics, including:

   * Breakthrough Therapies
   * Case Studies for Quality
   * Center Updates
   * Clinically Relevant Specifications
   * Continuous Manufacturing
   * Compliance Updates  Etc.,

Over the past 5 years, more than 525 senior level executives leading financial operations within the life science industry have participated in the Q1 Life Science CFO Strategic Governance Forum, engaging with like-minded executives and leading solution providers to rise to the challenge of an evolving health policy landscape, changing consumer perceptions and the financial impact that regulatory & reimbursement models are having on revenue, resource allocation and profitability. Working with leaders representing the top echelon of the industry, Q1 has established a networking and discussion-based format which allows participants an opportunity to truly engage in conversation, problem solving and solution-based conversation which have immediate impact on overcoming corporate challenges.

The Ministry of Science, Technology & Innovation (MOSTI), BioEconomy Corporation are proud to be the host of BioMalaysia & Asia Pacific Bioeconomy 2017. Jointly organised with MyEvents International, the event has seen phenomenal growth over the years. BioMalaysia & Asia Pacific Bioeconomy 2017 has established and continues to be the leading gathering for industry professions in the region.

Malaysia had quickly recognised the importance of having a bioeconomy and had taken critical steps to ensure it became one of the most competitive biotechnology hubs in the Asia Pacific region. It has coordinated and intensified national efforts to harness the bioeconomy’s potential through the implementation of the Bioeconomy Transformation Programme (BTP).

It now serves as a valuable platform for the birth of fresh ideas, practical solutions and effective collaborations between Malaysian and global biotechnology industry participants. BioMalaysia & Asia Pacific Bioeconomy 2017 will be showcasing the latest technologies, innovation and products from major local, regional and international biotechnology companies. Occupying two halls, exhibitors and participants are expected from United Kingdom, Australia, Korea, United States of America, Japan, Hong Kong, Taiwan, China, India, Vietnam, Thailand, Indonesia and other developing and advanced biotechnology countries. Attendees are guaranteed to be updated on the latest developments and trends which are currently taking place in the biotechnology industry. Exhibitors will also be allowed to invite an unlimited number of customers, contacts and potential buyers to BioMalaysia & Asia Pacific Bioeconomy 2017 and to increase the number of leads.
REASONS TO PARTICIPATE IN BIOMALAYSIA & ASIA PACIFIC BIOECONOMY 2017 EXHIBITION:

•    Networking opportunities with more than 10,000 targeted visitors from all over the world
•    Meet international and local thought leaders and decision makers
•    Get the latest scientific & business updates from industry players
•    Launch your new products & services during the event to maximise response
•    Meet potential partners through our business matching program
•    Attend conferences and listen to experts on latest happenings and future trends

TECHNOLOGY SHOWCASE PITCHING
Technology showcase / pitching is a platform where innovative and exciting researchers from our local universities pitch their businesses to an audience of experienced, talented business professionals that are looking for a new challenge and thrive on the buzz of working within bio-based entrepreneurial companies.

This unique event brings together leading pharma, device and biotech professionals from across the Midwest region. After a hugely successful launch event in 2016, the Clinical Trials Supply Midwest Conference will be returning to Chicago for its 2nd edition, with more content and senior level speakers than before. The Clinical Trial Supply stream will also now be run across the full 2 days due to increased demand.

This two-day event will focus on the most pressing issues facing the industry. The event offers a perfect platform for collaborating and building relationships between sponsors and vendors to facilitate the formation of new partnerships and strengthening existing relationships.

2017 Key Speakers:
•    Shan Rahman, Director, Global Project Management, Takeda Pharmaceuticals
•    Ruth Wu-Wong, CSO, Vidasym
•    Saheed O. Muhammed, Supervisory Import Specialist, United States Customs and Border Protection (US CBP)
•    David Adams, Clinical Supplies Lead, Shire

2017 Key Sessions:
•    Preparing shipments for global locations, outlining best practice and guidelines for international drug supply
•    Exploring your clinical trial imports and exports to ensure a smooth transition through US Customs
•    Navigating the path of new drug development in China: Experience of an US small biotech company
•    GMP best practice for Direct to Patients and Virtual Clinical Trials exploring the requirements for delivering drug supply 

Care & Rehabilitation Expo China (“CR Expo”) has been successfully held for 10 sessions. As the only fair of national level for disabled and elderly persons’ products and tools, as well as China’s Biggest Care & Rehabilitation Expo, CR Expo brings together the most advanced and most updated technologies, achievements and products from the rehabilitation, assistive device, elderly care and health industries, with an aim to build a multi-functional and all-dimensional platform for leading the future development of the industries.

Amplifying Market and Patient Access through Securing Prime Formulary Position with Comprehensive Awareness of Managed Care Utilization Processes, Policy Changes Impacting Medicare & Medicaid Trends, and Innovative Contracting Strategies

As health policy within the United States continues to evolve, with a new administration promising a restructure of the existing Affordable Care Act, executives responsible for managed market strategic accounts face an uncertain future for the coverage and reimbursement of vital health products, and look to ensure continued funding for life-altering treatments from both public and private payers. Hearing from payers directly on topics such as utilization management, exclusion and prior authorization models and network design will provide immediate impact on the bottom line of pharmaceutical corporations as organizations look to maximize the inclusion of products on formulary lists through the provision of high level, robust data and relationship management methods. Following on payer discussions, experts will discuss changes to Medicaid payment models and the continued influence of complex value assessment and cost-reduction strategies.

Course "The A to Z's of Microbial Control, Monitoring, Validation and Troubleshooting of Pharmaceutical Water Systems" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Overview:

This course is designed to provide a microbiology-focused education about all aspects of water systems and how biofilm manages to thrive there. Prior microbiological education or training, though a plus, is not a requirement because engineers and other non-biologists also need this training if they are involved with any aspect of water systems. The instructor will provide the necessary background needed to understand this very important subject matter. This understanding is essential to the proper design, validation, operation, monitoring, maintenance, troubleshooting, and excursion investigations of a high purity water system. Without this understanding, water system control consists of a set of rules that often don't work and can cause very costly system downtime or even product recalls, and leaves the user without a clue as to what went wrong or how to effectively fix it so it doesn't recur.

With the long-awaited addendum of the ICH E6 guidelines on the horison, now more than ever is the time to convene with industry leading experts to understanding its implications on risk, identification, evaluation, control, review and reporting. Join us in Barcelona for CBI and UBM's 2nd annual Global Risk-Based Monitoring conference to gain robust strategies that will aid in reducing the complexities of implementing efficient RBM methodologies and gain real-life study examples from leading industry experts on your most pressing challenges.

Benchmark Against Industry Leaders To:

•    Gain insight into regulatory expectations for ICH E6 and RBM
•    Benchmark against global industry leaders from around the world
•    Analyse requirements for a formal corrective action preventative action (CAPA) process for ensuring clinical trial management improvement following non-compliance
•    Evaluate implementation approaches, challenges and solutions for in-sourced, outsourced and hybrid models to RBM
•    Develop scalable and adaptable RBM models
•    Build a foundation for a sound risk-based monitoring process through supporting technology
•    Distribute monitoring activities between central monitors and
•    field monitors
•    Develop techniques for queries and analysis based on critical to quality variables

The goal of this Symposium is to provide a forum for the discussion of recent developments in CE analysis of protein, nucleotide and small molecule pharmaceuticals. The presentations and workshops will be devoted completely to practical concerns to strengthen the use of CE within the biotechnology and pharmaceutical industries. Applications will highlight uses of CE in various areas of product development including high throughput screening, formulation studies, process development, product characterization and validated lot release and stability testing.

The Symposium will feature presentations from leading experts within the industries and the regulatory agencies such as FDA, Health Canada and EMA. The workshops will allow for open discussions of specific techniques and/or applications including protein analysis, carbohydrate analysis, CE/MS, oligonucleotide and chiral separations as well as validation of CE assays for product release.

As in past years, CASSS (California Separation Science Society), a not-for-profit professional association designed to organize symposia and provide other educational and networking opportunities for separation, pharmaceutical and bioanalytical scientists throughout the world, will organize the Symposium.

The focus of this Symposium is the application of mass spectrometry (MS) for product characterization, process monitoring, formulation development and release testing in the pharmaceutical industry. Since mass spectrometry is used routinely for a wide array of applications, the meeting will provide scientists in the industry an opportunity       to share their data and learn from their colleagues. Although most of the applications may deal with biopharmaceuticals (proteins, DNA, viral vectors), applications for conventional pharmaceuticals will also be discussed. The Symposium will be held over a period of two and a half days and cover case studies and workshops (industrial, vendor and regulatory) devoted to practical concerns in the use of MS within the biotechnology and pharmaceutical industries.

Key issues for discussion:

•    Utility of MS as an alternative to conventional assays such as peptide mapping, ion exchange, capillary electrophoresis, as well as for the analysis of process-related impurities, such as host cell proteins;
•    Introduction of MS in the QC laboratory, validation/transfer/compliance strategy, system suitability/assay acceptance criteria;
•    Expectations from regulatory agencies for MS based assays for product characterization, release and stability;
•    Technical challenges regarding quantitation, ionization, higher order structure analysis, etc.;
•    Applications of MS for high throughput screening of cell-lines, raw materials, in-process samples;
•    Benchmarking of new technology

With a 9-year track record of successfully bringing to market the latest developments and insights from decision makers, the Pharma Regulatory Affairs Summit remains the only such conference in Asia. Part of the PharmaCon suite of events, the conference affords you the opportunity of getting hot of the press information and networking across various pharma industry segments.

Conference Highlights:

•    Regional Government updates on initiatives, reducing backlogs, new guidelines
•    Drug approval bottlenecks - And how to work with regulators to optimise timelines
•    Pharmacovigilance Regulations - REMS vs RMP, PSUR Submissions, and other updates
•    Product Registration, Submission & Approval - Masterclass focusing on the region
•    Supply Chain, Labelling and Distribution  - Standards and compliance strategies required

The 16th annual Laboratory Informatics Forum 2017 is designed to help you maximise the potential of your informatics software with case studies on streamlining LIMS processes, designing R&D facilities towards lab automation and a pre conference focus day designed to ensure your data is validated and inspection ready!

This Forum is the longest running and most established summit in Europe, with industry experts attending this summit from around the world, with high level discussion surround the key challenges in this area, you will ensure to gain further understanding and novel approaches towards enhancing your IT software.

Whether it surrounds the security of your processes, enhancing a global network or successfully achieving automated facilities and infrastructure, the answer is waiting for you in Amsterdam!

This Summit is focused on Cancer Immunotherapy, the most promising new cancer treatment approach since the development of the first chemotherapies. This summit brings together leading industry professionals in order to expand the scientific horizons of Cancer Immunotherapy, and discuss the latest advances and improvements in research and development.

We will discuss key findings, including critical insights, as well as recommendations for accelerating development in the field.

Key Practical Learning Points of the Summit:

    Advanced methods, technological developments and strategies in Cancer Immunotherapy
    The success of antibodies in therapeutics and engineering
    The true potential of the next generation immune checkpoint pathways
    Revolutionary cancer treatment with personalised cancer vaccines
    Reinforcing anti-tumour immunity
    Biomarkers’ responses
    Managing unique immune-mediated adverse reactions and toxicity effects
    Progressive genetic engineering techniques
    Preclinical and clinical progress in Cancer Immunotherapy
    CAR T-Cell Therapy: A game changer in cancer treatment
    Regulatory aspects of the EU and the rest of the world

India Lab expo, India’s largest exhibition on laboratory, scientific, analytical and biotechnology sector attracts international as well as Indian manufacturers and distributors. Decision makers from sectors like hospitals, diagnostic labs, oil & petroleum, chemical, cosmetics and Government departments can be met at the tradeshow.

The Precision Medicine and Biomarkers Leaders Summit will provide a forum to network, learn and engage with senior representatives of leading pharmaceutical and biotech companies worldwide.

More intimate roundtable discussions will also provide an opportunity for you and your peers to cover, in detail, issues such as fulfilling the potential of big data, conducting precision medicine clinical trials and advancing liquid biopsies to the clinic.

Ensuring Compliant Handling and Protection of Data, both Patient & Corporate, through Risk-Based Approaches to 3rd Party Assessments, Strong Internal Controls & Proactive Prevention of Breaches through Vulnerability Testing & Incident Response Management

Corporations large and small face the increasingly difficult task of securing internal networks against threats and vulnerabilities, both from external and internal sources, a challenge which is of considerable concern to life science information security executives, responsible for the safety and privacy of both patient as well as corporate data. New patient data privacy regulations enacted in Europe are of particular concern as corporations look to work and collaborate with research facilities and patients in the development of the next generation of medical products. With data being shared across networks, through big data cloud applications and across continents, the ability to secure information is of paramount importance.

From vetting third party partners, from software and security measures to contract research organizations, information security executives within the life sciences industry are facing a time of considerable change and threat. Taking a risk based approach to securing networks against threats; from the creation of strong internal controls to guide staff, to the regular conduct of penetration testing and incident response programming, executives must develop a responsive and agile team. Unlike traditional information security conferences, this educational platform will focus on the specific needs of life science companies, providing a unique opportunity for two engaging days of education and knowledge share at an industry peer level.

As the global healthcare industry grows, temperature controlled logistics rapidly evolves along with it. With ever-changing global regulatory requirements, a more diverse array of biopharma products entering the supply, and new technology emerging daily; companies face the challenge of constantly adapting their supply chain processes to stay ahead of the curve.

Responding to the evolution within the industry, the 15th Annual Global Forum has changed as well with an updated look, color scheme, and topic focus. This elevated brand identity allows us to follow suit with the industry, remain at the forefront of innovation, and embody the high level of quality the event delivers each year.

Welcome to the Annual International Conference on Pharmacology and Pharmaceutical Sciences (PHARMA). The conference aims to explore pharmacology, its relation with pharmaceutical sciences and application in the development of healthcare products.

Through sharing and networking, PHARMA 2017 will provide an opportunity for researchers, practitioners and educators to exchange research evidence, practical experiences and innovative ideas on issues related to pharmacology and pharmaceutical sciences.

The global injectable drug delivery market is expected to grow at 12.5% CAGR from now until 2022, reaching USD $797.22 billion by 2022!

While pre-filled syringes and closely related injectable devices have been around for decades, both innovations and regulatory environment are evolving rapidly. Drug and device developers need to catch up to ensure a safe and quality injection system.

Building on previous success, the 7th edition of PFS & Injectables is returning to San Diego in September. With our growing engaged community, you can expect interactive discussions and case studies to help you enhance your device quality with evolving therapeutics needs.